Bone Biologics
Bone Biologics Corp.
Bone Biologics Corp. operates in the biotechnology sector, focusing on products that enhance bone growth and regeneration. The company's primary aim is to develop and commercialize NELL-1, a proprietary protein that has shown potential in accelerating bone repair and treating spinal fusion. Bone Biologics targets medical conditions requiring bone regeneration, such as spinal disorders, osteoporosis, and other orthopedic and neurosurgical needs. The innovations by Bone Biologics are poised to influence both the healthcare and biotechnology industries by offering alternatives to existing bone graft solutions. As Bone Biologics continues its research and development efforts, it aims to address critical gaps in surgical outcomes with products that enhance patient recovery.
WebsiteCompany Information
Location
2 Burlington Woods Drive
Burlington, MA, 01803
United States